virtual

Babyscripts raises $12M, plans to expand to all 50 states

The maternal care startup is backed by major health systems including MemorialCare Health System, whose innovation arm led the most recent funding round. Babyscripts offers a mobile app providing education and resources for the pregnancy and postpartum journey.

Geisinger rolls out platform for virtual monitoring of chronic disease patients

Developed by Noteworth, the ConnectedCare365 application will enable Geisinger clinicians to virtually monitor patient vital signs and intervene when needed. The platform will be used for several clinical initiatives, including chronic condition management and behavioral health.

Care.coach takes aim at senior loneliness with round-the-clock virtual pets

Armed with a tablet and virtual pet companion, California-based startup care.coach is aiming to alleviate senior loneliness — an issue that has worsened amid the Covid-19 pandemic. The company, which won the health IT track of the Pitch Perfect contest at MedCity INVEST, aims to fulfill seniors’ medical and social needs through access to health …

Care.coach takes aim at senior loneliness with round-the-clock virtual pets Read More »

The 10th Anniversary Reaxys PhD Prize Symposium: A Virtual Success

No one anticipated that the 10th anniversary Reaxys PhD Prize Symposium would be a virtual event, but as we discussed earlier on in this blog, most gatherings of scientific researchers have had to go online this year because of COVID-19. As it turned out, the virtual symposium was a very special event in its own …

The 10th Anniversary Reaxys PhD Prize Symposium: A Virtual Success Read More »

Oregon Health & Science University, GE set up state’s first virtual ICU program

The academic medical center collaborated with GE Healthcare to set up the first virtual intensive care unit program in the state, which will help the organization extend its critical care expertise across rural areas and manage bed capacity amid climbing Covid-19 cases.

Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020

Shots: The company presented the new data of its T-cell engaging bispecific Abs, mosunetuzumab, glofitamab and cevostamab at ASH 2020, demonstrating encouraging activity across multiple types of blood cancer Roche divulges that its mosunetuzumab & glofitamab showed promising responses across multiple types of NHL, including R/R FL & DLBCL, reinforcing from the P-I/Ib GO29781 study …

Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020 Read More »

Roche Presents Results of Hemlibra Reinforcing the Long-Term Benefits for Hemophilia A at ASH 2020

Shots: The 4 pivotal HAVEN studies (HAVEN-1, 2, 3, 4) included pooled data from 401 people with hemophilia A with/ out factor VIII inhibitors, with a median duration efficacy period of 120.4wks. Hemlibra maintained low treated bleed rates with ABR remaining low throughout the evaluation period at 1.4. The proportion of participants who experienced 0 …

Roche Presents Results of Hemlibra Reinforcing the Long-Term Benefits for Hemophilia A at ASH 2020 Read More »

How to make an impact at a virtual congress

More competition than ever before The pharmaceutical industry has long relied on congresses to build relationships with customers and to showcase the latest data and information on new additions to the pipeline. However, COVID-19 has changed the congress experience significantly. Social distancing and travel restrictions have forced congress organizers to make a tough decision between …

How to make an impact at a virtual congress Read More »